Home/Pipeline/Immuron ETEC Candidate

Immuron ETEC Candidate

Prevention of ETEC‑related travellers' diarrhoea

Phase 2Active

Key Facts

Indication
Prevention of ETEC‑related travellers' diarrhoea
Phase
Phase 2
Status
Active
Company

About Immuron

Australian biotech delivering oral polyclonal antibodies from bovine colostrum for GI disease prevention and treatment.

View full company profile